Impacts & Achievements
Of the global production of COVID-19 vaccines are from DCVMN member manufacturers
DCVMN member companies manufacture 61 different types of vaccines, covering the most used and needed vaccines worldwide
8 vaccines technologies
A total of 8 different vaccine technology platforms are being used to develop COVID-19 vaccines between all of our 20 members that are engaging in the COVID-19 vaccine effort
Of the vaccines manufactured in the Network have WHO Prequalification
The vaccines manufactured by DCVMN members are supplied to 170 countries, covering many MICs, LMICs and LICs
The topics of the publications vary between advancing innovation for vaccine manufacturers from developing countries, DCVMN’s contribution to COVID-19 vaccines capacity, developing-country vaccine manufacturers’ technical capabilities and acceleration of vaccine supply.